{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:15:38Z","timestamp":1790507738583,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3846,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/labinvest.2012.69","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T08:44:54Z","timestamp":1335170694000},"page":"1058-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact"],"prefix":"10.1016","volume":"92","author":[{"given":"Guillaume","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gu\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Mich\u00e8le Rosa","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice E","family":"Poubelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2012.69_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2012.69_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2012.69_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/bmj.3.5768.236","article-title":"Research into psoriasis\u2014the last decade","volume":"3","author":"Shuster","year":"1971","journal-title":"BMJ"},{"key":"10.1038\/labinvest.2012.69_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jid.1968.37","article-title":"Abnormal cell proliferation in psoriasis","volume":"50","author":"Weinstein","year":"1968","journal-title":"J Invest Dermatol"},{"issue":"Suppl 36","key":"10.1038\/labinvest.2012.69_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2133.1990.tb02877.x","article-title":"Four years of experience with cyclosporin A for psoriasis","volume":"122","author":"Powles","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","article-title":"Immunopathogenesis of psoriasis","volume":"16","author":"Sabat","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib8","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V83.9.2580.2580","article-title":"T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28","volume":"83","author":"Nickoloff","year":"1994","journal-title":"Blood"},{"key":"10.1038\/labinvest.2012.69_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12514646","article-title":"Characterization of skin-infiltrating lymphocytes in patients with psoriasis","volume":"96","author":"Nikaein","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib10","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2012.69_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90464-Z","article-title":"Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis","volume":"338","author":"Prinz","year":"1991","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2012.69_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines","volume":"94","author":"Nestle","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2012.69_bib19","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1038\/jid.1995.18","article-title":"Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia","volume":"105","author":"Bata-Csorgo","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI117659","article-title":"Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes","volume":"95","author":"Bata-Csorgo","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/eji.1830240315","article-title":"T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products","volume":"24","author":"Prinz","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2012.69_bib23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1038\/labinvest.2012.69_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.clindermatol.2007.08.011","article-title":"The cytokine and chemokine network in psoriasis","volume":"25","author":"Nickoloff","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archderm.1992.01680210057007","article-title":"T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis","volume":"128","author":"Chang","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jdermsci.2008.07.009","article-title":"Development of an in vitro psoriatic skin model by tissue engineering","volume":"53","author":"Jean","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1038\/labinvest.2012.69_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0305-4179(93)90028-7","article-title":"Improvement of human keratinocyte isolation and culture using thermolysin","volume":"19","author":"Germain","year":"1993","journal-title":"Burns"},{"key":"10.1038\/labinvest.2012.69_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/labinvest.3700701","article-title":"Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro","volume":"88","author":"Chakravarti","year":"2008","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2012.69_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/247553031016a00102","article-title":"Cellular interactions in vitro: psoriatic keratinocytes enhance T lymphocyte survival","volume":"16","author":"Rosa Fortin","year":"2010","journal-title":"Psoriasis Forum"},{"key":"10.1038\/labinvest.2012.69_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","article-title":"Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes","volume":"25","author":"Albanesi","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0190-9622(89)70083-9","article-title":"T lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon","volume":"20","author":"Nickoloff","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1523-1747.ep12494196","article-title":"Interleukin-1 receptor antagonist production by human keratinocytes","volume":"98","author":"Bigler","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib33","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1111\/1523-1747.ep12505698","article-title":"Interleukin-1 in human skin: dysregulation in psoriasis","volume":"95","author":"Cooper","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000248361","article-title":"Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids","volume":"179","author":"Gruaz","year":"1989","journal-title":"Dermatologica"},{"key":"10.1038\/labinvest.2012.69_bib35","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.0022-202X.2005.23684.x","article-title":"Counter-regulation of interleukin-1alpha (IL-1alpha) and IL-1 receptor antagonist in murine keratinocytes","volume":"124","author":"Mee","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cyto.2005.12.001","article-title":"Interleukin-1: a key inflammatory mediator in psoriasis?","volume":"33","author":"Mee","year":"2006","journal-title":"Cytokine"},{"key":"10.1038\/labinvest.2012.69_bib37","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1111\/1523-1747.ep12874991","article-title":"Interleukin-1 and interleukin-6 in psoriasis","volume":"95","author":"Prens","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.138.6.791","article-title":"Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor","volume":"138","author":"Creamer","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2012.69_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1038\/labinvest.2012.69_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1189\/jlb.70.4.617","article-title":"A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases","volume":"70","author":"Albanesi","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1038\/labinvest.2012.69_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.114707","article-title":"Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines","volume":"107","author":"Giustizieri","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/labinvest.2012.69_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1989.tb07759.x","article-title":"Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-I (ICAM-I) antigens","volume":"120","author":"Griffiths","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1523-1747.ep12462420","volume":"90","author":"Nickoloff","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2006.07573.x","article-title":"T cell\/keratinocyte interactions in psoriasis: where is the trigger?","volume":"156","author":"Simonart","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","article-title":"Immunobiologics in the treatment of psoriasis","volume":"123","author":"Chong","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1038\/labinvest.2012.69_bib47","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.144.12.4593","article-title":"IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta","volume":"144","author":"Cooper","year":"1990","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib48","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.158.6.2955","article-title":"The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis","volume":"158","author":"Debets","year":"1997","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI115896","article-title":"Interleukin-1 receptor antagonist in normal and psoriatic epidermis","volume":"90","author":"Hammerberg","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004030050319","article-title":"IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis","volume":"290","author":"Hammerberg","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1038\/labinvest.2012.69_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib52","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2353\/ajpath.2009.080973","article-title":"Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines","volume":"175","author":"Kirschner","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2012.69_bib53","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.167.4.1323","article-title":"Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1)","volume":"167","author":"Dustin","year":"1988","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.2012.69_bib54","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1600-0625.2006.00486.x","article-title":"The CX3CL1-CX3CR1 system and psoriasis","volume":"15","author":"Plant","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib55","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.1365-2133.2001.04219.x","article-title":"Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine","volume":"144","author":"Raychaudhuri","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0923-1811(03)00031-8","article-title":"Human keratinocytes express fractalkine\/CX3CL1","volume":"31","author":"Sugaya","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1038\/labinvest.2012.69_bib57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib58","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitroin situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Piskin","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib59","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2012.69_bib60","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2012.69_bib61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2012.69_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1523-1747.ep12312542","article-title":"Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells","volume":"105","author":"Detmar","year":"1995","journal-title":"J Invest Dermatol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722013241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722013241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:40:28Z","timestamp":1758397228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722013241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0023683722013241"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2012.69","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2012.69","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}